ストックスクリーナーアプリを入手
81.79
0.57%
0.46
アフターアワーズ：
81.79
前日終値:
$81.33
開ける：
$79.2
24時間の取引高:
982.04K
Relative Volume:
0.62
時価総額：
$2.38B
収益：
$861.31M
当期純損益:
$53.12M
株価収益率:
47.38
EPS:
1.7262
ネットキャッシュフロー:
$85.01M
1週間 パフォーマンス:
-13.40%
1か月 パフォーマンス:
-14.33%
6か月 パフォーマンス:
-36.53%
1年 パフォーマンス:
-55.63%
1日の値動き範囲:
$78.45
$81.93
1週間の範囲:
$77.75
$97.52
52週間の値動き範囲:
$70.77
$203.12
Inspire Medical Systems Inc Stock (INSP) Company Profile
名前
Inspire Medical Systems Inc
セクター
電話
763-957-5037
住所
5500 WAYZATA BLVD, GOLDEN VALLEY
INSP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
81.79 | 2.36B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2026-01-22 | ダウングレード | Truist | Buy → Hold |
| 2025-12-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | アップグレード | Truist | Hold → Buy |
| 2025-11-25 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | アップグレード | Stifel | Hold → Buy |
| 2025-11-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | ダウングレード | Jefferies | Buy → Hold |
| 2025-09-22 | ダウングレード | UBS | Buy → Neutral |
| 2025-09-02 | 開始されました | Evercore ISI | Outperform |
| 2025-08-05 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | ダウングレード | Truist | Buy → Hold |
| 2024-11-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-05-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-04-19 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2024-01-02 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-13 | アップグレード | Goldman | Neutral → Buy |
| 2022-12-13 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-11-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-11-03 | アップグレード | Oppenheimer | Underperform → Perform |
| 2020-09-22 | 開始されました | JP Morgan | Overweight |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-06 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-07-15 | 開始されました | Goldman | Buy |
| 2020-06-18 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-18 | 開始されました | Lake Street | Buy |
| 2020-04-28 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | 開始されました | Piper Sandler | Overweight |
| 2020-01-28 | 開始されました | Oppenheimer | Underperform |
| 2020-01-27 | 開始されました | Oppenheimer | Underperform |
| 2019-11-06 | アップグレード | Berenberg | Sell → Hold |
| 2019-02-05 | 開始されました | Dougherty & Company | Buy |
| 2018-11-28 | 開始されました | Berenberg | Sell |
| 2018-10-29 | 開始されました | Leerink Partners | Outperform |
| 2018-05-29 | 開始されました | Guggenheim | Buy |
| 2018-05-29 | 開始されました | Stifel | Buy |
| 2018-05-29 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Inspire Medical Systems Inc (INSP) 最新ニュース
Forecasting The Future: 19 Analyst Projections For Inspire Medical Systems - Benzinga
Equities Analysts Issue Forecasts for INSP FY2027 Earnings - MarketBeat
A Look At Inspire Medical Systems (INSP) Valuation After CMS Reimbursement Uncertainty - simplywall.st
Y Intercept Hong Kong Ltd Grows Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Baillie Gifford & Co. Sells 29,538 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Assessing Inspire Medical Systems (INSP) Valuation After A Difficult Year For Shareholder Returns - Yahoo! Finance Canada
Wells Fargo is bullish on Inspire Medical Systems, Inc. (INSP) despite short-term reimbursement concerns - MSN
Inspire Medical Systems, Inc. (NYSE:INSP) Given Average Rating of "Hold" by Brokerages - MarketBeat
Analyst Upgrade: Will ZKH Group Limited Depositary Receipt benefit from geopolitical trendsWeekly Gains Report & Community Consensus Picks - baoquankhu1.vn
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $96 - 富途资讯
(INSP) Volatility Zones as Tactical Triggers - Stock Traders Daily
Inspire downgraded at Oppenheimer following CMS NCD correction - MSN
Inspire Medical Systems (NYSE:INSP) Shares Down 7.5% After Analyst Downgrade - MarketBeat
Inspire Medical Systems Board Under Investigation, 2025 Earnings Guidance Cut by Over 80% - Intellectia AI
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors - marketscreener.com
Truist Securities downgrades Inspire Medical stock on coding setback By Investing.com - Investing.com Canada
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz
Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Truist Financial - MarketBeat
CMS removes OSA coverage for Inspire Medical Systems reimbursement uplift - Investing.com Canada
Inspire Medical (INSP) Faces Downgrade Amid Coding Changes - GuruFocus
Inspire Medical stock tumbles after CMS removes sleep apnea coverage By Investing.com - Investing.com Canada
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Finviz
Oppenheimer downgrades Inspire Medical stock on CMS reimbursement reversal By Investing.com - Investing.com Canada
INSP Shares Drop Following CMS Correction and Analyst Downgrade - GuruFocus
Inspire Medical (INSP) Faces Medicare Reimbursement Adjustment - GuruFocus
Inspire Medical Systems (NYSE:INSP) Lowered to "Market Perform" Rating by Oppenheimer - MarketBeat
Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns - Finviz
Aug Macro: What are Inspire Medical Systems Incs growth levers2025 Earnings Surprises & Daily Entry Point Alerts - baoquankhu1.vn
2 Reasons to Watch INSP and 1 to Stay Cautious - The Globe and Mail
Update Report: Can Inspire Medical Systems Inc sustain earnings growthJuly 2025 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn
Inspire Medical Systems, Inc. (INSP): Stock Analysis Highlights 50% Potential Upside for Investors - directorstalkinterviews.com
A Look At Inspire Medical Systems (INSP) Valuation After New Growth Guidance And CFO Appointment - Sahm
Inspire Medical Systems, Inc. (INSP): A Bull Case Theory - Finviz
Swing Trade: What is JYNTs P E ratio telling usWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Wells Fargo Maintains Overweight Rating on INSP, Lowers Price Ta - GuruFocus
Will New CFO Hire And Inspire V Launch Plus 2026 Guidance Change Inspire Medical Systems' (INSP) Narrative? - Yahoo Finance
Insider Sell: John Rondoni Sells Shares of Inspire Medical Syste - GuruFocus
JPM26: Inspire Medical Systems projects a strong 2026 - Yahoo Finance
Inspire appoints Matt Osberg as CFO - MedTech Dive
Impulse Dynamics® Announces New Chief Financial Officer - The Manila Times
Inspire Medical Systems appoints Matt Osberg as new CFO By Investing.com - Investing.com Nigeria
Inspire Medical Systems (NYSE:INSP) Insider Sells $10,900.00 in Stock - MarketBeat
Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results - TipRanks
Jefferies raises Inspire Medical Systems stock price target to $100 on strong Q4 - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) sets CFO transition, preliminary 2025 results - Stock Titan
INSP: Inspire V drives growth with improved outcomes, strong guidance, and ongoing innovation - TradingView — Track All Markets
INSP: Inspire 5's launch accelerates growth, innovation, and patient outcomes, with strong 2026 outlook - TradingView — Track All Markets
Inspire Medical names new CFO, reports preliminary Q4 results - MassDevice
Inspire Medical Systems announces Q4 and FY25 guidance, appoints new CFO - MSN
INSP Forecasts 10%-11% Growth by 2025 - GuruFocus
Inspire Medical Systems (INSP) Reports Strong Revenue Growth in 2025 - GuruFocus
Inspire Medical Systems Inc (INSP) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
0.96%
大文字化:
|
ボリューム (24 時間):